14-02-2019 дата публикации
Номер: US20190048018A1
Принадлежит:
The presently described technology provides compositions comprising aryl carboxylic acids and, for example NSAIDs, chemically conjugated to oxycodone (4,5-α-epoxy-14-hydroxy-17-methylmorphinan-6-one) to form novel prodrugs/compositions of oxycodone, including benzoates, salicylates, propionates, fenamates, and acetates, which have a decreased potential for abuse of oxycodone. The present technology also provides methods of treating patients, pharmaceutical kits and methods of synthesizing conjugates of the present technology. 2. A composition comprising a compound of claim 1 , a salt thereof claim 1 , or a combination thereof.3. The composition of claim 2 , wherein the salt is a pharmaceutically acceptable salt.4. The composition of claim 3 , wherein the pharmaceutically acceptable salt is selected from the group consisting of an acetate claim 3 , L-aspartate claim 3 , besylate claim 3 , bicarbonate claim 3 , carbonate claim 3 , D-camsylate claim 3 , L-camsylate claim 3 , citrate claim 3 , edisylate claim 3 , formate claim 3 , fumarate claim 3 , gluconate claim 3 , hydrobromide/bromide claim 3 , hydrochloride/chloride claim 3 , D-lactate claim 3 , L-lactate claim 3 , D claim 3 ,L-lactate claim 3 , D claim 3 ,L-malate claim 3 , L-malate claim 3 , mesylate claim 3 , pamoate claim 3 , phosphate claim 3 , succinate claim 3 , sulfate claim 3 , bisulfate claim 3 , D-tartrate claim 3 , L-tartrate claim 3 , D claim 3 ,L-tartrate claim 3 , meso-tartrate claim 3 , benzoate claim 3 , gluceptate claim 3 , D-glucuronate claim 3 , hybenzate claim 3 , isethionate claim 3 , malonate claim 3 , methylsufate claim 3 , 2-napsylate claim 3 , nicotinate claim 3 , nitrate claim 3 , orotate claim 3 , stearate claim 3 , tosylate claim 3 , thiocyanate claim 3 , acefyllinate claim 3 , aceturate claim 3 , aminosalicylate claim 3 , ascorbate claim 3 , borate claim 3 , butyrate claim 3 , camphorate claim 3 , camphocarbonate claim 3 , decanoate claim 3 , hexanoate claim 3 , cholate claim 3 , ...
Подробнее